Base award

Active Definitive Contract Awarded Last action

Contract number
75N93023C00046
Awardee
Awarding agency
Obligated
$11,194,341

Award facts

Opportunity
  • 75N93022R00009 Solicitation number
Contract value 100% obligated
$11,194,341.00 Current and potential, with all options
Completion date 62% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 24 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21201, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 · EO14398; "adjuvant development of the TLR4 ligand BECC470S for use in influenza, S. Aureus, and P. Aeruginosa vaccines" $2,032,644
Change Order P00006 · EOI::EO: radical transparency about wasteful spending: EOI bilateral modification to descope for FY2025 cost savings: "adjuvant development of the TLR4 ligand… $2,018,199
Other Administrative Action P00005 $0
Vendor DUNS or Name Change - Non-Novation P00004 $0
Change Order P00003 $3,500,000
Exercise an Option P00002 $1,746,827
Other Administrative Action P00001 $0
Original award $1,896,671

About this award

The National Institute of Allergy and Infectious Diseases awarded a $11.194 million definitive contract to University Of Maryland, Baltimore for adjuvant development of the TLR4 ligand BECC470s for use in influenza, S. aureus, and P. aeruginosa vaccines on September 30, 2023, with performance through September 29, 2028.

Work is performed in Baltimore, Maryland under firm fixed-price terms. The scope includes development research aligned with Executive Order 14398. University Of Maryland, College Park, University of Missouri System (Curators of the University of Missouri), and The Washington University serve as subcontractors on the effort.

In FY2025, the contract invoiced $1.9 million across 6.6 FTEs and 13,722 contractor hours at a blended government-paid rate of $137.19 per hour. Subcontractors accounted for approximately 22 percent of contractor hours in that fiscal year.

Subawards

Subcontractor Amount Awarded
University Of Maryland, College Park BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s $50,000
University Of Missouri System BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s. $1,141,625
The Washington University BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s. $177,270
University Of Maryland, College Park BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s $400,000
Subcontractor not on record BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s. $1,171,220
The Washington University BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s $467,258
University Of Missouri System BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s $372,775
The Washington University BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s. $177,270
The Washington University BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s. $233,629
University Of Missouri System BASE AWARD Adjuvant development of the TLR4 ligand - BECC470s $444,434

Quick answers

Who was awarded contract 75N93023C00046?

75N93023C00046 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2023.

How much is contract 75N93023C00046 worth?

The government has obligated $11,194,341 on 75N93023C00046.

Was contract 75N93023C00046 competed?

The extent of competition for 75N93023C00046 was full and open competition. The government received 24 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award